奈特林
肝星状细胞
转移
癌症研究
生物
细胞生物学
维甲酸
胰腺癌
下调和上调
信号转导
轴突引导
癌症
细胞培养
内分泌学
轴突
遗传学
基因
生物化学
作者
Crissy Dudgeon,Anthony Casabianca,Chris R. Harris,Charline Ogier,Mélanie Bellina,Stephany Fiore,Agnès Bernet,Benjamin Ducarouge,David Goldschneider,Xiaoyang Su,Jason Robert Pitarresi,Aram F. Hezel,Subhajyoti De,Wade C. Narrow,Fady K. Soliman,C.P. Shields,Debora Barbosa Vendramini Costa,Orjola Prela,Lan Wang,Igor A. Astsaturov
出处
期刊:Cell Reports
[Cell Press]
日期:2023-11-01
卷期号:42 (11): 113369-113369
被引量:41
标识
DOI:10.1016/j.celrep.2023.113369
摘要
The biology of metastatic pancreatic ductal adenocarcinoma (PDAC) is distinct from that of the primary tumor due to changes in cell plasticity governed by a distinct transcriptome. Therapeutic strategies that target this distinct biology are needed. We detect an upregulation of the neuronal axon guidance molecule Netrin-1 in PDAC liver metastases that signals through its dependence receptor (DR), uncoordinated-5b (Unc5b), to facilitate metastasis in vitro and in vivo. The mechanism of Netrin-1 induction involves a feedforward loop whereby Netrin-1 on the surface of PDAC-secreted extracellular vesicles prepares the metastatic niche by inducing hepatic stellate cell activation and retinoic acid secretion that in turn upregulates Netrin-1 in disseminated tumor cells via RAR/RXR and Elf3 signaling. While this mechanism promotes PDAC liver metastasis, it also identifies a therapeutic vulnerability, as it can be targeted using anti-Netrin-1 therapy to inhibit metastasis using the Unc5b DR cell death mechanism.
科研通智能强力驱动
Strongly Powered by AbleSci AI